Paul Reider serves as Executive at Coherus BioSciences, Inc., where they oversee executive responsibilities. Since joining the company, Paul Reider has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 20, 2024 involved selling 4,854 shares valued at $11.8K.
Paul Reider currently holds 81,277 shares of Coherus BioSciences, Inc. (CHRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Reider has been a net neutral trader of CHRS stock. They have purchased $0 and sold $0 worth of shares.
Paul Reider's most recent insider trade was on Jan 20, 2024, when they sold 4,854 shares at $2.44 per share.
Get notified when new Form 4 filings are submitted
| $2.92 |
| Discretionary |
| Dec 13, 2023 | CHRS | $4.9K | Payment | 2,049 | $2.37 | Discretionary |
| Apr 1, 2023 | CHRS | $16.8K | Payment | 2,451 | $6.84 | Discretionary |